Where can I buy Abiomed shares?
Shares of ABMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Abiomed's stock price today?
Should you hold Abiomed (aBMD) stock?
The consensus among Wall Street analysts is that investors should "hold" Abiomed stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ABMD, but not buy additional shares or sell existing shares. View analyst ratings for Abiomed or view top-rated stocks.
How much does Abiomed make a year?
Abiomed has a market capitalization of $14.19 billion and generates $847.52 million in revenue each year. The medical equipment provider earns $225.52 million in net income (profit) each year or $3.24 on an earnings per share basis. How many employees does Abiomed have?
Does Abiomed have an upside of 20%?
According to analysts' consensus price target of $375.50, Abiomed has a forecasted upside of 20.4% from its current price of $311.94. Abiomed has only been the subject of 2 research reports in the past 90 days. Abiomed has received 532 “outperform” votes. (Add your “outperform” vote.) Abiomed has received 249 “underperform” votes.
Is Abiomed stock a buy?
Out of 4 analysts, 1 (25%) are recommending ABMD as a Strong Buy, 0 (0%) are recommending ABMD as a Buy, 2 (50%) are recommending ABMD as a Hold, 0 (0%) are recommending ABMD as a Sell, and 1 (25%) are recommending ABMD as a Strong Sell.
Is Abiomed publicly traded?
Abiomed is a publicly-traded medical devices company that develops and manufactures external and implantable circulatory support devices.
What does Abiomed Inc do?
Abiomed (NASDAQ: ABMD) is a leading provider of groundbreaking medical technology that provides circulatory and oxygenation support. The Impella® heart pump platform is designed to enable the heart to rest and recover by improving blood flow and/or temporarily assisting with the pumping function of the heart.
What industry is Abiomed?
medical device companyAbiomed Inc (Abiomed) is a medical device company that develops, manufactures and markets circulatory support devices.
When did Abiomed go public?
1987: Applied Biomedical is merged into newly formed Abiomed, which is taken public. 1994: The National Institutes of Health (NIH) selects company to receive funding for final stage of artificial heart development.
Who is the CEO of Abiomed?
Michael R. Minogue (Apr 6, 2004–)Abiomed / CEO
Is Abiomed a good company to work for?
Is ABIOMED a good company to work for? ABIOMED has an overall rating of 3.5 out of 5, based on over 273 reviews left anonymously by employees. 58% of employees would recommend working at ABIOMED to a friend and 78% have a positive outlook for the business.
Who started Abiomed?
Abiomed (NSDQ:ABMD) founder and cardiovascular pioneer David Lederman last week died of pancreatic cancer at the age of 68.
Who invented Impella?
Thorsten SiessThorsten Siess, Abiomed's Chief Technology Officer and Inventor of Impella® Shares his Insights on the Impella Platform of Heart Pumps.
Is ABIOMED stock a Buy, Sell or Hold?
ABIOMED stock has received a consensus rating of hold. The average rating score is and is based on 1 buy ratings, 7 hold ratings, and 5 sell ratings.
What was the 52-week low for ABIOMED stock?
The low in the last 52 weeks of ABIOMED stock was 226.93. According to the current price, ABIOMED is 112.53% away from the 52-week low.
What was the 52-week high for ABIOMED stock?
The high in the last 52 weeks of ABIOMED stock was 378.96. According to the current price, ABIOMED is 67.38% away from the 52-week high.
What are analysts forecasts for ABIOMED stock?
The 13 analysts offering price forecasts for ABIOMED have a median target of 306.31, with a high estimate of 375.00 and a low estimate of 217.00. T...
Where is Abiomed headquartered?
Does ABMD pay dividends?
The company was founded in 1981 and is headquartered in Danvers, Massachusetts.
What is Abiomed medical?
ABMD does not currently pay a dividend.
How many articles has The Fool written on Abiomed?
Abiomed is a provider of medical devices in circulatory support and offer a continuum of care in heart recovery to acute heart failure patients.
When will the ABMD earnings call end?
The Fool has written over 200 articles on Abiomed.
Is medical device a lucrative business?
ABMD earnings call for the period ending June 30, 2021.
What time does AMC stock trade?
Medical devices can be ultra reliable, lucrative business , but there are plenty of ways for companies to blow it, too.
What time do you trade in the pre market?
AMC Entertainment Holdings, Inc. Class A Common Stock. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices.
What is the official website of Abiomed?
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. Stock prices may also move more quickly in this environment.
When is Abiomed earnings call?
The official website for Abiomed is www.abiomed.com.
What is MarketBeat community ratings?
How can I listen to Abiomed's earnings call? Abiomed will be holding an earnings conference call on Thursday, August 5th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 404-537-3406 with passcode "5929017".
How much does Abiomed make?
MarketBeat's community ratings are surveys of what our community members think about Abiomed and other stocks. Vote “Outperform” if you believe ABMD will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ABMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
How many research reports has Abiomed been subject to?
Abiomed has a market capitalization of $14.48 billion and generates $847.52 million in revenue each year. The medical equipment provider earns $225.52 million in net income (profit) each year or $4.94 on an earnings per share basis.
What is the ABMD symbol?
Abiomed has only been the subject of 1 research reports in the past 90 days.
What is the P/E ratio of Abiomed?
Abiomed trades on the NASDAQ under the ticker symbol "ABMD."
Abiomed (ABMD) Beats on Q3 Earnings, Narrows FY22 Guidance
The P/E ratio of Abiomed is 100.61, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 20.34.
Abiomed (ABMD) Q3 Earnings and Revenues Top Estimates
Abiomed's (ABMD) strength in Impella product revenues drives its Q3 top line.
These 4 Measures Indicate That Abiomed (NASDAQ:ABMD) Is Using Debt Safely
Abiomed (ABMD) delivered earnings and revenue surprises of 15.31% and 3.21%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
